NEW YORK(GenomeWeb) – Exosome Diagnostics said today that it has raised $17.6 million in a second Series B financing round.

Combined with funds from a first round, the firm said it has raised a total of $44.7 million in its Series B overall.

Participating investors in the second round included Forbion Capital Partners, NGN Capital, Arcus Ventures, Tiger Management, and CD Ventures, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.